Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029615

Chief Scientific Officer sold 2,373 shares at $25.85 ($61,342)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Beskrovnaya Oxana Chief Scientific Officer 2024-03-07 Sale 10b5-1 −2,373 $25.85 $61,342 154,433 D: show line 1 in the form
Open-market sales · 2,373 sh · avg $25.85 · $61,342
Loading xslF345X05/ownership.xml…